Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
G Chir ; 40(4): 304-307, 2019.
Article in English | MEDLINE | ID: mdl-32011981

ABSTRACT

Breast metastasis from extra-mammary malignancy is extremely rare with an incidence from 0.4% to 1.3%. Several types of malignancies that most commonly metastasize to the breast include leukemia, lymphoma, and melanoma. AIM: We report a case of a 57-year-old male with a history of non-small cell lung cancer (NSCLC) who manifested a left breast mass, two years and four months after the initial diagnosis and treatRomament of NSCLC. METHOD: Physical examination revealed a poorly defined mass in the upper outer quadrant of the left breast, suspicious for breast cancer. After mammography results, the patient underwent Fine Needle Aspiration that was indicative of cancer. He underwent then modified radical mastectomy and axillary lymph node dissection. Histology and immunohistochemical analyses were conducted, that revealed a NSCLC that metastasized to the left breast. RESULTS: Finally, the prognosis of the patient was poor, as NSCLC relapsed from IIB to stage IV. CONCLUSIONS: An accurate differentiation of metastasis to the breast from primary breast cancer is of paramount importance because the therapeutic approach and prognosis of the two differ significantly.


Subject(s)
Adenocarcinoma/surgery , Breast Neoplasms, Male/surgery , Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms , Mastectomy, Modified Radical , Unilateral Breast Neoplasms/surgery , Adenocarcinoma/drug therapy , Adenocarcinoma/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms, Male/drug therapy , Breast Neoplasms, Male/secondary , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/secondary , Humans , Lung Neoplasms/therapy , Male , Middle Aged , Neoplasm Recurrence, Local/drug therapy , Unilateral Breast Neoplasms/drug therapy , Unilateral Breast Neoplasms/secondary
3.
Neuroradiol J ; 26(1): 71-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23859171

ABSTRACT

We report our two-year experience in the endovascular treatment of brain aneurysms in relation to their parent artery wall. We prospectively recorded patients with intracranial aneurysms (107 ruptured - 38 unruptured) treated with coiling during a two-year period: 145 patients, 94 females and 51 males - mean age 56 years. The aneurysms were divided into side-wall (A) and bifurcation (B) groups. A total occlusion rate was noted in post-embolization angiograms in 101 aneurysms (70%) with a morbidity of 4%. No angiographic recurrence arose in the six-month follow-up. The two groups had a similar total occlusion rate (68.31% and 71.8% respectively), while the complication rate was 3% in group A and 4.7% in group B. Significant differences between the two groups were noted in the number of assisted coiling cases: 28 out of 60 cases (46.7%) in group A - 14 out of 85 cases (16.5%) in group B. Further statistical analysis showed strong dependencies for the type of endovascular procedure between the ruptured and unruptured aneurysms in both groups (p 0.000<0.05), but no dependencies between the aneurysm occlusion rate and the ruptured or non-ruptured aneurysms, or between the occlusion rate and the type of endovascular procedure (p 0.552>0.05 and 0.071>0.05 respectively). In conclusion, the anatomic relation of the aneurysm sac with the wall of the parent artery is important, as significant differences in endovascular practice, devices and techniques were noted between side-wall and bifurcation aneurysms.


Subject(s)
Arteries/pathology , Embolization, Therapeutic/methods , Intracranial Aneurysm/surgery , Aged , Aged, 80 and over , Cerebral Angiography , Female , Humans , Male , Middle Aged , Postoperative Complications/pathology , Postoperative Complications/physiopathology , Retrospective Studies , Severity of Illness Index , Subarachnoid Hemorrhage/etiology , Surgical Instruments/adverse effects , Treatment Outcome
5.
Ann Nutr Metab ; 50(4): 330-8, 2006.
Article in English | MEDLINE | ID: mdl-16825761

ABSTRACT

AIM: To provide estimates of the prevalence of obesity, overweight and body fat distribution among the adult population of Greece. DESIGN: Epidemiological, cross-sectional nationwide survey providing self-reported data. SUBJECTS: A total of 17,341 men and women aged from 20 to 70 years and classified into five 10-year age groups participated. The selection was conducted by stratified sampling through household family members of Greek children attending school. MEASUREMENTS: The participants reported data on weight, height, waist and hip circumference. BMI and waist-to-hip ratio were calculated. Abdominal obesity was defined as waist circumference > or = 102 cm in men and > or = 88 cm in women. RESULTS: In the total population, the mean BMI was 26.5 kg/m2, (27.3 in men, 25.7 in women). The overall prevalence of obesity was 22.5%, (26% in men, 18.2% in women) while that of overweight was 35.2% (41.1% in men, 29.9% in women). The percentages of obesity and overweight in men were similar in almost all age groups, while in women they progressively increased with age. Abdominal obesity was more frequent among women than men (35.8 vs. 26.6%, respectively), especially after the age of 50. CONCLUSIONS: Excess body weight is reaching epidemic proportions in Greece and obesity rates are among the highest, if not the highest, in Western society. The problem affects particularly men, and women after menopause. Interestingly, more women than men present with abdominal obesity. Preventive and treatment strategies are urgently needed to stop the obesity epidemic in this Mediterranean European country.


Subject(s)
Abdominal Fat/metabolism , Body Composition/physiology , Health Surveys , Obesity/epidemiology , Adult , Age Distribution , Aged , Body Mass Index , Cross-Sectional Studies , Female , Greece/epidemiology , Humans , Male , Middle Aged , Prevalence , Self Disclosure , Sex Distribution , Waist-Hip Ratio
6.
Conf Proc IEEE Eng Med Biol Soc ; 2005: 2429-32, 2005.
Article in English | MEDLINE | ID: mdl-17282728

ABSTRACT

Evidence based medicine is the clinical practice that uses medical data and proof in order to make efficient decisions in the field of the medical domain. Information technology services play a crucial role in exploiting the huge size of medical data involved. Furthermore health care society nowadays utilizes clinical guidelines [1][2] as a new assistant in their efforts to improve clinical decision efficacy. Clinical guidelines provide for the decrease of variance in medical decision making, leading to an improvement of clinical outcome. Therefore this paper focus is twofold. Improving the provision and visualization of disease specific, clinical data, providing for it's faster and more efficient use[l0], while making sure that consistency appears in the clinical practice by importing clinical guidelines in decision support systems.

7.
Cancer Invest ; 22(6): 897-912, 2004.
Article in English | MEDLINE | ID: mdl-15641488

ABSTRACT

Worldwide, esophageal carcinoma is a common gastrointestinal cancer with a high mortality. The incidence of adenocarcinoma of the esophagus is increasing in the western world, but squamous cell carcinoma remains dominant in the underdeveloped parts of the world. Both types of esophageal carcinoma remain equally virulent. Currently, there are no optimal preventative screening programs available and most patients present with advanced or metastatic disease. Although many options are available for improving diagnostic accuracy, a single method has not displayed significant advantages over the others. In addition, selecting a superior treatment regimen has not surfaced. Preferred resection techniques exist, but one method has not illustrated improvements in survival over the others. A lack of improved survival rates with single modality therapies has led to a multi modality approach. However, developments in neoadjuvant and adjuvant therapies have led to mixed conclusions. Collectively, past studies have not shown an optimal neoadjuvant or adjuvant regimen in terms of survival benefit. This review highlights existing staging modalities and treatment regimens for esophageal carcinoma, in an effort to illustrate the controversial nature surrounding its management.


Subject(s)
Carcinoma, Squamous Cell , Esophageal Neoplasms , Antineoplastic Agents , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/therapy , Combined Modality Therapy , Esophageal Neoplasms/diagnosis , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/therapy , Humans , Neoadjuvant Therapy , Neoplasm Staging
8.
Surg Endosc ; 14(9): 834-8, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11000364

ABSTRACT

BACKGROUND: Advanced laparoscopic procedures require prolonged pneumoperitoneum. Increased intra-abdominal pressure causes a number of hemodynamic changes including a drop in cardiac output, but it is unclear whether there is a direct effect on cardiac contractility. In this experimental study, we sought to determine whether there is a direct impact of pneumoperitoneum on cardiac contractility. We also examined the time-related changes taking place during the insufflation period. METHODS: Six young pigs were anesthetized and mechanically ventilated. Pneumoperitoneum was established by insufflating carbon dioxide to a pressure of 15 mmHg and maintained for a period of 180 min. Hemodynamic parameters including left ventricular dP/dT were invasively recorded every 15 min. All hemodynamic changes were statistically evaluated, and parameters were correlated with time. RESULTS: Cardiac output decreased with insufflation from a baseline of 3.37 +/- 0.34 lt/min and reached the lowest value at 165 min of pneumoperitoneum (2.86 +/- 0.30 l/min; p = 0.023). Systemic vascular resistance (SVR) significantly increased from 2236 +/- 227 dyne/s/cm(5) to a maximum of 3774 +/- 324 dyne/s/cm(5) (p = 0.005). Left ventricular dP/dT maximum did not change significantly with insufflation. The decrease in cardiac output strongly correlated with the increase in SVR (r = -0.949). Time of insufflation correlated with cardiac output (r = -0.762) and dP/dT maximum (r = -0.727). CONCLUSIONS: Pneumoperitoneum at 15 mmHg negatively affects cardiac output without significantly affecting cardiac contractility. A significant increase in SVR appears to be the driving event for the decreased cardiac output. Prolonged pneumoperitoneum may have an additional negative effect on hemodynamic parameters.


Subject(s)
Myocardial Contraction , Pneumoperitoneum, Artificial , Animals , Blood Pressure , Cardiac Output , Stroke Volume , Swine , Time Factors , Vascular Resistance
9.
Am J Surg ; 179(1): 37-41, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10737576

ABSTRACT

BACKGROUND: It has been postulated that segmental duodenal resection (SR) is not an adequate operation for patients with adenocarcinoma of the duodenum and that pancreaticoduodenectomy (PD) is the procedure of choice, regardless of the tumor site. However, data from previous studies do not clearly support this position. METHODS: We reviewed the records of 63 patients treated for duodenal adenocarcinoma from 1979 through 1998. Perioperative outcome, patient survival, and extent of lymphadenectomy were compared in patients who underwent PD and SR. RESULTS: The overall morbidity for PD and SR was 27% and 18%, respectively (not significant [NS]). Patients who underwent SR had a 5-year survival of 60% versus 30% for patients who underwent PD (NS). Lymph node status was a prognostic factor for survival (P = 0.014). The mean number of lymph nodes in the specimens was 9.9 +/- 2.1 for PD and 8.3 +/- 4.4 for SR (NS). CONCLUSIONS: Segmental duodenal resection for patients with duodenal adenocarcinoma is associated with acceptable postoperative morbidity and long-term survival. The procedure is especially well suited for distal duodenal tumors. Clearance of lymph nodes and outcome are comparable to PD.


Subject(s)
Adenocarcinoma/surgery , Duodenal Neoplasms/surgery , Pancreaticoduodenectomy , Actuarial Analysis , Adenocarcinoma/mortality , Duodenal Neoplasms/mortality , Female , Humans , Lymph Node Excision , Male , Middle Aged , Proportional Hazards Models , Survival Analysis
10.
J Surg Oncol ; 72(4): 225-9, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10589038

ABSTRACT

BACKGROUND AND OBJECTIVES: Estrogen receptors (ER) and progesterone receptors (PR) have been detected in both normal and malignant colonic mucosa, but the prognostic value of this observation is unknown. We aimed to define the prognostic significance of the presence of ER and PR in malignant cells from colorectal adenocarcinoma specimens. METHODS: An immunohistochemical assay for ER and PR was performed on paraffinized sections from 65 colorectal adenocarcinoma specimens. Survival curves were analyzed to define the prognostic implications of ER and PR. RESULTS: Twenty nine (45%) tumors tested receptor positive (32% for ER and 23% for PR). Tumors of advanced stage were more likely to express receptors than early stage tumors (56% vs. 32%; P = 0.01). Median survival of patients with neoplasms expressing PR was 30 months. For patients whose tumors did not express any receptors, median survival had not been reached at the time of follow-up (P = 0.04). Similarly, patients with tumors expressing both receptors had significantly reduced survival (median survival = 20 months; P = 0.003). CONCLUSIONS: Expression of receptors for sex steroids correlates with advanced stage disease. Expression of PR by the tumor cells is associated with a shorter patient survival. The results suggest that sex steroids may play a role in carcinogenesis and tumor progression.


Subject(s)
Adenocarcinoma/metabolism , Colorectal Neoplasms/metabolism , Intestinal Mucosa/chemistry , Receptors, Estrogen/biosynthesis , Receptors, Progesterone/biosynthesis , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Male , Middle Aged , Prognosis , Retrospective Studies , Survival Analysis
11.
Surg Oncol ; 8(1): 35-42, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10885392

ABSTRACT

The authors sought to examine the utility of resection in conjunction with adjuvant chemotherapy for treatment of metastases from breast cancer isolated to the liver or lungs. Limitations of regional therapy were examined and potential agents for systemic therapy were reviewed. As resection of metastases is a controversial therapeutic approach, no clinical trials are available for review. Rather, evidence for a potential role for surgery rests on retrospective studies of small series of patients. Technical advances have rendered resection of liver and lung metastases safe. Long-term results as reported by other investigators support the role of metastasectomy in selected patients. The site of failure following ablation of liver metastases is usually in the liver. Following resection of lung metastases, nonpulmonary and disseminated recurrences are most common. Adjuvant therapy with docetaxel or any other agent or combination with significant activity against visceral metastases might potentiate long-term results.


Subject(s)
Breast Neoplasms/pathology , Liver Neoplasms/secondary , Liver Neoplasms/surgery , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Female , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...